Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

A new immunotherapy target called a cryptic antigen may be key in helping the immune system fight ovarian cancer.

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

Clinical outcomes from a prospective study of comprehensive genomic testing in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). This is an ASCO Meeting Abstract from the ...

Immune therapy has transformed how cancer is treated, but many tumors continue to evade these treatments, thanks to their ...

Equities research analysts at StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Get Free Report) in a research report issued to clients and investors on Saturday. The ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.